Cargando…
GADL1 variant and medication adherence in predicting response to lithium maintenance treatment in bipolar I disorder
BACKGROUND: Genetic variants and medication adherence have been identified to be the main factors contributing to lithium treatment response in bipolar disorders. AIMS: To simultaneously examine effects of variant glutamate decarboxylase-like protein 1 (GADL1) and medication adherence on response to...
Autores principales: | Chen, Chih-Ken, Lee, Chau-Shoun, Chen, Hsuan-Yu, Wu, Lawrence Shih-Hsin, Chang, Jung-Chen, Liu, Chia-Yih, Cheng, Andrew Tai-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Psychiatrists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015003/ https://www.ncbi.nlm.nih.gov/pubmed/27703793 http://dx.doi.org/10.1192/bjpo.bp.116.002881 |
Ejemplares similares
-
Lithium and GADL1 regulate glycogen synthase kinase-3 activity to modulate KCTD12 expression
por: Wu, Tai-Na, et al.
Publicado: (2019) -
Effects of GADL1 overexpression on cell migration and the associated morphological changes
por: Wu, Tai-Na, et al.
Publicado: (2019) -
Immunophenotypes associated with bipolar disorder and lithium treatment
por: Wu, Tai-Na, et al.
Publicado: (2019) -
PS48. Genome-wide association study of psychotic subtype in bipolar I disorder
por: Lee, Chau-Shoun, et al.
Publicado: (2016) -
Genome-Wide Association Study of Lithium-Induced Dry Mouth in Bipolar I Disorder
por: Wu, Lawrence Shih-Hsin, et al.
Publicado: (2021)